全文获取类型
收费全文 | 41591篇 |
免费 | 3448篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 267篇 |
儿科学 | 1642篇 |
妇产科学 | 1428篇 |
基础医学 | 5108篇 |
口腔科学 | 673篇 |
临床医学 | 5902篇 |
内科学 | 7451篇 |
皮肤病学 | 660篇 |
神经病学 | 4090篇 |
特种医学 | 1254篇 |
外科学 | 4130篇 |
综合类 | 674篇 |
一般理论 | 49篇 |
预防医学 | 5477篇 |
眼科学 | 694篇 |
药学 | 2915篇 |
中国医学 | 53篇 |
肿瘤学 | 2637篇 |
出版年
2023年 | 252篇 |
2021年 | 586篇 |
2020年 | 532篇 |
2019年 | 771篇 |
2018年 | 909篇 |
2017年 | 745篇 |
2016年 | 781篇 |
2015年 | 891篇 |
2014年 | 1207篇 |
2013年 | 1859篇 |
2012年 | 2715篇 |
2011年 | 2707篇 |
2010年 | 1553篇 |
2009年 | 1403篇 |
2008年 | 2363篇 |
2007年 | 2543篇 |
2006年 | 2387篇 |
2005年 | 2401篇 |
2004年 | 2252篇 |
2003年 | 2117篇 |
2002年 | 1998篇 |
2001年 | 763篇 |
2000年 | 709篇 |
1999年 | 675篇 |
1998年 | 422篇 |
1997年 | 329篇 |
1996年 | 293篇 |
1995年 | 330篇 |
1994年 | 295篇 |
1993年 | 262篇 |
1992年 | 497篇 |
1991年 | 500篇 |
1990年 | 514篇 |
1989年 | 451篇 |
1988年 | 455篇 |
1987年 | 468篇 |
1986年 | 391篇 |
1985年 | 432篇 |
1984年 | 361篇 |
1983年 | 288篇 |
1982年 | 228篇 |
1981年 | 191篇 |
1980年 | 181篇 |
1979年 | 300篇 |
1978年 | 247篇 |
1976年 | 188篇 |
1974年 | 197篇 |
1973年 | 192篇 |
1972年 | 182篇 |
1969年 | 182篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
72.
73.
74.
D. Baker G. Pryce L. K. James K. Schmierer G. Giovannoni 《European journal of neurology》2020,27(2):221-228
Clinical trials are probably the most informative experiments to help an understanding of multiple sclerosis (MS) biology. Recent successes with CD20‐depleting antibodies have focused attention towards B cell subsets as important mediators in MS. The trial of tabalumab (NTC00882999), which inhibits B cell activation factor (BAFF), is reported and reviewed and this trial is contrasted with the trial on the inhibition of a proliferation‐inducing ligand (APRIL) and BAFF using atacicept (NCT00642902). Both tabalumab and atacicept induce depletion of mature B cells and inhibit antibody formation, but they fail to deplete memory B cells and do not inhibit relapsing MS. Atacicept is reported to augment memory B cell responses and may precipitate relapse, suggesting the importance of APRIL. However, BAFF inhibition can enhance peripheral blood memory B cell responses, which was not associated with augmented relapse. Although other interpretations are possible, these data further support the hypothesis that memory B cells may be of central importance in relapsing MS, as they are the major CD20+ B cell subset expressing APRIL receptors. They also suggest that quantitative and/or qualitative differences in B cell responses or other factors, such as an immune‐regulatory effect associated with APRIL, may be important in determining whether MS reactivates following neutralization of peripheral B cell maturation and survival factors. 相似文献
75.
76.
Mina Jane Zafar Thomas Kallemose Mostafa Benyahia Lars Bo Ebskov Jeannette
stergaard Penny 《Acta orthopaedica》2020,91(4):444
Background and purpose — Total ankle arthroplasties (TAAs) have larger revision rates than hip and knee implants. We examined the survival rates of our primary TAAs, and what different factors, including the cause of arthritis, affect the success and/or revision rate.Patients and methods — From 2004 to 2016, 322 primary Hintegra TAAs were implanted: the 2nd generation implant from 2004 until mid-2007 and the 3rd generation from late 2007 to 2016. A Cox proportional hazards model evaluated sex, age, primary diagnosis, and implant generation, pre- and postoperative angles and implant position as risk factors for revision.Results — 60 implants (19%) were revised, the majority (n = 34) due to loosening. The 5-year survival rate (95% CI) was 75% (69–82) and the 10-year survival rate was 68% (60–77). There was a reduced risk of revision, per degree of increased postoperative medial distal tibial angle at 0.84 (0.72–0.98) and preoperative talus angle at 0.95 (0.90–1.00), indicating that varus ankles may have a larger revision rate. Generation of implant, sex, primary diagnosis, and most pre- and postoperative radiological angles did not statistically affect revision risk.Interpretation — Our revision rates are slightly above registry rates and well above those of the developer. Most were revised due to loosening; no difference was demonstrated with the 2 generations of implant used. Learning curve and a low threshold for revision could explain the high revision rate.Arthritis in the ankle often develops earlier than in the hip or knee, and 70% have a traumatic etiology (Saltzman et al. 2005, Brown et al. 2006). Total ankle arthroplasty (TAA) can be indicated for severe arthritis in the ankle joint, but the anatomical preconditions, like a small surface area and high stress from compression and torque (Bouguecha et al. 2011, Kakkar and Siddique 2011), makes it less durable than hip and knee prosthetics. The Hintegra TAA, a 3-component mobile bearing, uncemented implant (Hintermann et al. 2004) is widely used and results from the development center demonstrate survival rates of 94% and 84% after 5 and 10 years’ follow-up (Barg et al. 2013). This is considerably more than the survival rates from national registries. Labek et al. (2011) demonstrated that development centers report only half of the revision rate that can be found in the few existing national registers. In a systematic review of primary Agility total ankle arthroplasty (DePuy Synthes Orthopedics, Warsaw, IN, USA), the author (Roukis 2012) found that the incidence of complications increased from 7% to 12%, in studies where the inventor was excluded. Similar results were found by Prissel and Roukis (2013), who found an increased incidence of complications from 6% to 13% in studies where the inventor or faculty consultants were excluded. These studies indicated the risk of selection (inventor) and publication (conflict of interest) bias.Planning and surgical technique, including significant experience, are mandatory for a successful outcome. The better result from development centers may reflect, besides the above-mentioned bias, that there is a long learning curve and that the indication for revision surgery varies.We examined the survival rates of primary Hintegra TAAs performed at Hvidovre Hospital, with revision rate as outcome. We report primary diagnosis for primary TAA and examine whether sex, generation of the implant, preoperative angles and implant position affect the revision rate. 相似文献
77.
78.
ABSTRACTCommunication between health professionals and patients is an intergroup phenomenon where the health professional has the most power and status. Over the past few decades, there has been a steady increase in the availability to patients of information about healthcare and specific diseases on the Internet. In this paper, we ask whether the use of Internet health information assists patients to manage their consultations with health professionals better and whether it alters the intergroup dynamic by providing a more equal status for patients. In this study 370 participants from Australia and Canada completed a survey that included a ‘willingness to communicate with health professionals’ scale. They also commented on their use and trust of Internet health information. Thematic analysis suggests that patients’ use of Internet health information serves as a broker between patients and their health provider in health consultations. We discuss the implications of these findings for health practitioners as they address how easier Internet access influences patient interactions with health professionals. We consider future research directions these finding provide in explaining communication behaviour in this context. 相似文献
79.
80.
Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study 下载免费PDF全文